Predictive markers for programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) axis blockade therapy in patients with metastatic melanoma (MM) von Kim, Dae Won, Chakravarti, Nitin, Trinh, VanAnh, Perdon, Karen Mae, McIntyre, Susan E, Prieto, Victor G., Hwu, Wen-Jen

Volltext

Safety and preliminary activity data from a single center phase II study of triplet combination of nivolumab (N) with dabrafenib (D) and trametinib (T) [trident] in patients (Pts)... von Tawbi, Hussein Abdul-Hassan, Amaria, Rodabe Navroze, Glitza, Isabella Claudia, Milton, Denai, Hwu, Wen-Jen, Patel, Sapna Pradyuman, Wong, Michael K.K., Yee, Cassian, Woodman, Scott Eric, McQuade, Jennifer Leigh, Hwu, Patrick, Perdon, Karen Mae, Shephard, Michael, Burton, Elizabeth M., Wargo, Jennifer Ann, Davies, Michael A.

Volltext

A single-institution experience with the pembrolizumab (PEM) Expanded Access Program (EAP) von Perdon, Karen Mae, Kim, Dae Won, Balmes, Gener C, Trinh, VanAnh, McIntyre, Susan E, Diab, Adi, Amaria, Rodabe Navroze, Patel, Sapna Pradyuman, Hwu, Patrick, James, Marihella, Philip, Ann, Vardeleon, Anna, Cain, Suzanne, Hwu, Wen-Jen

Volltext